Pancreatitis Trial, Recruiting NCT04095195 Sponsor: Associazione Italiana per lo Studio del Pancreas Condition: Pancreatitis
Back to Pancreatitis

Pancreatitis Trial, Recruiting

NCT04095195
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have at least two relatives who have had pancreatic cancer, and at least one of them is a close relative (such as a parent, sibling, or child), up to a third-degree relative (such as a great-grandparent or cousin)
  • You have a known gene change (mutation) in BRCA2, BRCA1, p16, or PALB2, AND at least one close or fairly close relative (parent, sibling, child, grandparent, aunt, or uncle) who has had pancreatic cancer
  • You have been diagnosed with FAMMM Syndrome (a condition linked to an increased risk of certain cancers, including melanoma) (confirm with trial site)
  • You have been diagnosed with Peutz-Jeghers Syndrome (a condition that causes growths in the digestive system and increases cancer risk)
  • You have a specific type of pancreatitis (inflammation of the pancreas) linked to changes in the PRSS-1, CFTR, or SPINK-1 genes
  • You have Lynch Syndrome AND at least one close or fairly close relative who has had pancreatic cancer

To take part in the imaging/scanning follow-up part of the trial, you also need to meet one of these age requirements:

  • You are at least 45 years old, OR at least 10 years younger than the youngest family member who was diagnosed with pancreatic cancer (for family history cases)
  • You are at least 40 years old, OR at least 5 years younger than the youngest family member diagnosed with pancreatic cancer (for those with hereditary pancreatitis, Lynch Syndrome, or BRCA1/2, PALB2, or p16 gene mutations with a family history of pancreatic cancer)
  • You are at least 30 years old (for those with FAMMM or Peutz-Jeghers Syndrome)

Who may not be able to join:

  • You are currently pregnant

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 00390458126009

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Associazione Italiana per lo Studio del Pancreas
Registry
ClinicalTrials.gov
Start date
20 August 2019
Est. completion
20 August 2044

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

This clinical study will assess the diagnostic yield of a clinical surveillance program for pancreatic neoplasia or predisposing conditions (PanIN, IPMNs) in high risk individuals

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov